Literature DB >> 17342104

AIDS gel's failure calls prevention approach into question.

Natasha Bolognesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17342104     DOI： 10.1038/nm0307-230b

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

2.  Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Authors:  Hubert Gaertner; Fabrice Cerini; Jean-Michel Escola; Gabriel Kuenzi; Astrid Melotti; Robin Offord; Irène Rossitto-Borlat; Rebecca Nedellec; Janelle Salkowitz; Guy Gorochov; Donald Mosier; Oliver Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

3.  Enhancement of HIV infection by cellulose sulfate.

Authors:  Wang Tao; Chris Richards; Dean Hamer
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

4.  Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

Authors:  Mimi Ghosh; Zheng Shen; John V Fahey; Susan Cu-Uvin; Kenneth Mayer; Charles R Wira
Journal:  Immunology       Date:  2009-07-18       Impact factor: 7.397

5.  Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge.

Authors:  Ronald S Veazey; Binhua Ling; Linda C Green; Erin P Ribka; Jeffrey D Lifson; Michael Piatak; Michael M Lederman; Donald Mosier; Robin Offord; Oliver Hartley
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.